Input your search keywords and press Enter.

Riyadh Hosts Experts in Oncology and Radiation Therapy Symposium

Riyadh Hosts Global Experts in 2nd Middle East Oncology and Radiation Therapy Symposium
Riyadh Hosts Global Experts in 2nd Middle East Oncology and Radiation Therapy Symposium

Saudi Arabia’s capital, Riyadh, is set to host the 2nd Middle East Oncology and Radiation Therapy Symposium, organized by Alfaisal University from November 9 to 11, 2023. The event will welcome 90 global speakers discussing the latest advancements in radiation therapy and oncology, spotlighting particularly on precise live radiation therapy and imaging techniques. The three-day symposium aims to foster discussions and share advancements made by research centers and universities globally.

Oncology and Radiation Therapy Symposium Global Participation:

The symposium is attracting participants from all Gulf oncology centers, represented by Sultan Qaboos Center, Kuwait Cancer Center, and oncology centers from Qatar, Bahrain, and the UAE. The event has garnered registration from over 1,500 professionals keen on attending from across the globe, underlining its international stature.

Oncology and Radiation Therapy Symposium Leadership:

The symposium is spearheaded by Dr. Saad Al Rashidi, the head of the Radiation Therapy Department at King Fahd Medical City’s Comprehensive Cancer Center. Dr. Al Rashidi accentuated that the event would feature more than 90 speakers and specialists from the US, Canada, most European countries, Australia, and also experts from the organizing body for radiation therapy globally, the American Society for Radiation Oncology, professors from the University of Sheffield, UK, and advanced oncology centers from various countries.

Aiming for Healthcare Advancements:

The event aims to enhance and evolve healthcare, focusing on radiation medicine applications, enabling practitioners to deliver safe, high-quality care to patients. Targeting professionals in diagnostic and interventional radiology, radiation therapy, medical physics, nuclear medicine, medical engineering, dosimetry, interventional cardiology, clinical sciences, neurosurgery, oncology sciences, nursing, technicians, students, and interested companies, it’s a comprehensive gathering of the medical community.

Specialized Scientific Tracks:

The symposium offers various specialized scientific tracks including diagnostic and interventional radiology, medical physics, nuclear medicine, radiation oncology, radiation protection, radiation emergency management, medical engineering, radiography technology, 3D printing and virtual reality, change management in healthcare, artificial intelligence and business intelligence, radiation therapy, and radiation medical education. It aims to exchange views, discuss current clinical applications, and innovative future approaches in radiation medicine, fostering a conducive environment for encouraging basic sciences, applied research, and clinical applications in radiation medicine.

Global Oncology and Radiation Associations’ Support:

This symposium and the establishment of the Middle East Association for Oncology and Radiation Therapy is supported by major global oncology associations. Additional backing comes from the European Society for Radiotherapy & Oncology, the Canadian Association of Radiation Oncology, the Australasian Brachytherapy Group, the Turkish Society for Radiation Oncology, the Pakistan Society of Clinical Oncology, and Saudi associations.

The Symposium in Riyadh is a monumental step towards fostering a global dialogue in oncology and radiation therapy advancements. By hosting this symposium, Saudi Arabia is positioning itself as a significant player in the global medical community, opening doors for future collaborations and advancements in oncology and radiation therapy. Through these discussions and the exchange of knowledge, the symposium hopes to contribute substantially to the evolving landscape of radiation medicine, both regionally and globally, paving the way for better patient care and innovative treatments in the oncology sector.

Short link :